SLC2A9-Mediated Uric Acid Homeostasis Modulates Apoptosis in TNBC
Breast Cancer: Targets and Therapy · 2026-06 · Volume 18 · 1-17
DOI: 10.2147/bctt.s606599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-06. Verfasst von Peng Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid, Breast and Hernia Surgery, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thyroid, Breast and Hernia Surgery, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
ORCID-Profile: Jinghui Mu
Zitieren
APA
Chen, P., Xu, J., Liang, Y., Mu, J., Feng, W., Liu, J., & Li, B. (2026). SLC2A9-Mediated Uric Acid Homeostasis Modulates Apoptosis in TNBC. Breast Cancer: Targets and Therapy, Volume 18, 1-17. https://doi.org/10.2147/bctt.s606599
Vancouver
Chen P, Xu J, Liang Y, Mu J, Feng W, Liu J, et al. SLC2A9-Mediated Uric Acid Homeostasis Modulates Apoptosis in TNBC. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-17. doi:10.2147/bctt.s606599
BibTeX
@article{Chen2026,
author = {Chen, Peng and Xu, Jiapeng and Liang, Yulong and Mu, Jinghui and Feng, Wenjing and Liu, Jiaming and Li, Bolun},
title = {SLC2A9-Mediated Uric Acid Homeostasis Modulates Apoptosis in TNBC},
journal = {Breast Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 18},
pages = {1--17},
doi = {10.2147/bctt.s606599}
}
EUVIMED